Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006523
Filing Date
2024-11-14
Accepted
2024-11-14 09:32:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 VERRICA PHARMACEUTICALS INC. p24-3029sc13ga.htm SC 13G/A 56895
  Complete submission text file 0000902664-24-006523.txt   58612
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Subject) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90530 | Film No.: 241457811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)